Chelsea Therapeutics International, Ltd. 4

4 · Chelsea Therapeutics International, Ltd. · Filed Jan 24, 2014

Form 4

Period: 2014-01-22

Director

Transactions

Award
Stock Option (Right to Buy)
2014-01-22+35,000→ 35,000 total
Exercise: $4.65Exp: 2024-01-22→ Common Stock (35,000 underlying)

Holdings

Common Stock
(indirect: By Children)
5,000
Common Stock
(indirect: By Children)
5,000
Common Stock
35,000
Stock Option (Right to Buy)
Exercise: $0.96Exp: 2023-01-07→ Common Stock (35,000 underlying)
35,000
Stock Option (Right to Buy)
Exercise: $1.15Exp: 2022-07-23→ Common Stock (35,000 underlying)
35,000
Common Stock
(indirect: By Children)
5,000
Stock Option (Right to Buy)
Exercise: $4.54Exp: 2022-01-25→ Common Stock (30,000 underlying)
30,000
Stock Option (Right to Buy)
Exercise: $1.77Exp: 2014-12-31→ Common Stock (50,000 underlying)
50,000
Stock Option (Right to Buy)
Exercise: $2.96Exp: 2020-01-19→ Common Stock (30,000 underlying)
30,000
Stock Option (Right to Buy)
Exercise: $5.25Exp: 2019-07-23→ Common Stock (35,000 underlying)
35,000
Stock Option (Right to Buy)
Exercise: $7.72Exp: 2021-01-11→ Common Stock (30,000 underlying)
30,000

Footnotes (9)

[F1]The shares are held in accounts for Mr. Rueckert's children for which he serves as custodian.
[F2]Option vests in four equal annual installments beginning on January 22, 2015.
[F3]Option vests upon a change in control of the Company.
[F4]Option vests in four equal annual installments beginning on January 7, 2014.
[F5]Option vests in four equal annual installments beginning on July 23, 2013.
[F6]Option vests in four equal annual installments beginning on January 25, 2013.
[F7]Option vests in four equal annual installments beginning on January 11, 2012.
[F8]Option vested in four equal annual installments beginning on January 19, 2011.
[F9]Option vested in four equal annual installments beginning on July 23, 2010.

Documents

1 file